Relief Therapeutics Holding AG (0QKQ.L) Stock Price
CHF2.7 0.9%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
3 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Relief Therapeutics Holding AG, AI stock picks, stock alerts and much more.
0QKQ.L AI Stock Analysis
AI stock analysis for 0QKQ.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Relief Therapeutics Holding AG (0QKQ.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Relief Therapeutics Holding AG (0QKQ.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Relief Therapeutics Holding AG (0QKQ.L), currently trading at CHF2.7, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0QKQ.L
-
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally.
-
Symbol
0QKQ.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
28M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394 0.9% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$134.6 0.4% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.15 1.5% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.17 0.5% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.09 1.2% |
5 |
News
0QKQ.L Alternative Data
Web Traffic
Relief Therapeutics Holding AG receives an estimated 367 monthly visitors to relieftherapeutics.com.
-
Web Traffic
367
-
Change from Previous Month
133.8%
-
3 Month Change
50.7%
-
YoY Change
50.7%
Twitter Followers
Relief Therapeutics Holding AG has 160 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.6% over the last month.
-
Twitter Followers
160
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0%
-
YoY Change
0%
Job Postings
Relief Therapeutics Holding AG currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Relief Therapeutics Holding AG has 8 employees.
-
LinkedIn Employees
8
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
11.1%
-
YoY Change
11.1%
News Mentions
Relief Therapeutics Holding AG was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Relief Therapeutics Holding AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
0QKQ.L Financials
0QKQ.L Key Metrics
-
Total Revenue
CHF2.8M
-
Net Income
-CHF12.6M
-
Earnings per Share
-CHF1
-
Free cash flow
CHF345K
-
EBITDA
-CHF14.2M
-
EBITDA Ratio
-5.00987
-
Total Assets
CHF53.2M
0QKQ.L 2-year Revenue & Income
0QKQ.L 2-year Free Cash Flow
0QKQ.L Technicals
0QKQ.L SMA
0QKQ.L RSI
FAQ
What's the current price of Relief Therapeutics Holding AG (0QKQ.L) Stock?
The price of an Relief Therapeutics Holding AG (0QKQ.L) share is CHF2.7.
What's the market cap of Relief Therapeutics Holding AG?
The current market cap of Relief Therapeutics Holding AG is 28M.
Should I buy or sell 0QKQ.L?
Relief Therapeutics Holding AG shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Relief Therapeutics Holding AG is better viewed as a hold or accumulate position while waiting for further developments.
Is Relief Therapeutics Holding AG a good investment?
The current analysis of Relief Therapeutics Holding AG's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Relief Therapeutics Holding AG's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Relief Therapeutics Holding AG (0QKQ.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Relief Therapeutics Holding AG stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Relief Therapeutics Holding AG (0QKQ.L) that investors often compare it to?
Relief Therapeutics Holding AG (0QKQ.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Relief Therapeutics Holding AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Relief Therapeutics Holding AG's stock price to be around CHF2.61 in 2026. Starting from the current price of CHF2.7, this represents a 3.5% change in price, indicating a neutral outlook for the stock.
How to buy Relief Therapeutics Holding AG (0QKQ.L) Stock?
Relief Therapeutics Holding AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Relief Therapeutics Holding AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.